Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF)’s chief financial officer Sath Nirmalananthan will be presenting and taking part in a panel discussion at the Sachs 10th Annual Oncology Innovation Forum on 31 May, at the beginning of the ASCO meeting. Nirmalananthan will be participating in the ‘Advanced Immunotherapies Panel: Cell Therapies & Cancer Vaccines’, alongside other companies including AstraZeneca, BTIG and Lumanity. The panel will discuss the current and future role of cell therapies and cancer vaccines from 11:40am to 12:30pm CDT.
Advertisement Go to Proactive UK Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Advertisement Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com